Implementation of HybridArc treatment technique in preoperative radiotherapy of rectal cancer: dose patterns in target lesions and organs at risk as compared to helical Tomotherapy and RapidArc

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Gevaert, Thierry ^a   Engels, Benedikt ^a   Garibaldi, Cristina ^b   Verellen, Dirk ^a   Deconinck, Peter ^a   Duchateau, Michael ^a   Reynders, Truus ^a   Tournel, Koen ^a   De Ridder, Mark ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Helical Tomotherapy; HybridArc; IMRT rectal cancer; Preoperative radiotherapy; RapidArc; Simultaneous integrated boost

Indexed keywords

ARTICLE; BLADDER; CLINICAL ARTICLE; DOSIMETRY; HUMAN; HYBRIDARC RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LYMPH NODE; PREOPERATIVE RADIOTHERAPY; RAPIDARC RADIOTHERAPY; RECTUM CANCER; TOMOTHERAPY; TREATMENT PLANNING;

HUMANS; ORGANS AT RISK; PARTICLE ACCELERATORS; PREOPERATIVE CARE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTAL NEOPLASMS;

EID: 84864366260     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-120     Document Type: Article

References (20)

1. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646. 10.1056/NEJMoa010580, 11547717.
2. Gerard JP, Chapet O, Nemoz C, et al. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The Lyon R96-02 randomized trial. J Clin Oncol 2004, 22:2404-2409. 10.1200/JCO.2004.08.170, 15197202.
3. Crane CH, Skibber JM, Birnbaum EH, et al. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2003, 57:84-89. 10.1016/S0360-3016(03)00532-7, 12909219.
4. Folkesson J, Birgisson H, Pahlman L, et al. Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on sur- vival and local recurrence rate. J Clin Oncol 2005, 23:5644-5650. 10.1200/JCO.2005.08.144, 16110023.
5. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740. 10.1056/NEJMoa040694, 15496622.
6. De Ridder M, Tournel K, Van Nieuwenhove Y, et al. Phase II study of preoperative helical Tomotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2008, 70(3):728-734. 10.1016/j.ijrobp.2007.07.2332, 17904302.
7. Engels B, De Ridder M, Tournel K, et al. Preoperative helical Tomotherapy and megavoltage computed tomography forrectal cancer: impact on the irradiated volume of small bowel. Int J Radiat Oncol Biol Phys 2009, 74(5):1476-1480. 10.1016/j.ijrobp.2008.10.017, 19231097.
8. Tournel K, De Ridder M, Engels B, et al. Assessment of in-trafractional movement and internal motion in radiotherapy of rectal cancer using megavoltage computed tomography. Int J Radiat Oncol Biol Phys 2008, 71:934-939. 10.1016/j.ijrobp.2008.02.032, 18514785.
9. Yu CX. Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to Tomotherapy. Phys Med Biol 1995, 40:1435-1439. 10.1088/0031-9155/40/9/004, 8532757.
10. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 2008, 35:310-317. 10.1118/1.2818738, 18293586.
11. Kuo Y-C, Chiu Y-M, Shih W-P, et al. Volumetric intensity-modulated arc (RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy. Radiat Oncol 2011, 6:76. 10.1186/1748-717X-6-76, 3138395, 21693003.
12. Robertson JM, Lockman D, Yan D, et al. The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2008, 70(3):413-418.
13. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissueto therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
14. Llacer J. Inverse radiation treatment planning using the Dynamically Penalized Likelihood method. Med Phys 1997, 24:1751-1764. 10.1118/1.597961, 9394282.
15. Duthoy W, De Gersem W, Vergote K, et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. Int J Radiat Oncol Biol Phys 2004, 60:294-806.
16. Hartford AC, Palisca MG, Eichler TJ, et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) Practice Guidelines for Intensity-Modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys 2009, 73:9-14. 10.1016/j.ijrobp.2008.04.049, 19100920.
17. Maso L, Casamassima F, Doro R. Quality-Assurance of volumetric modulated arc therapy: Evaluation and comparison of different dosimetric systems. Med Phys 2011, 38(2):612-621. 10.1118/1.3533900, 21452698.
18. Petoukhova AL, van Egmond J, Eenink MG, et al. The ArcCHECK diode array for dosimetric verification of HybridArc. Phys Med Biol 2011, 56:5411-5428. 10.1088/0031-9155/56/16/021, 21804180.
19. Hoogeman MS, Nuyttens JJ, Levendag PC, et al. Time dependence of intrafraction patient motion assessed by repeat stereoscopic imaging. Int J Radiat Oncol Biol Phys 2008, 70:609-618. 10.1016/j.ijrobp.2007.08.066, 17996389.
20. Hall EJ, Wuu C-S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 2003, 56:83-88. 10.1016/S0360-3016(03)00073-7, 12694826.